STADA Market Share Analysis for February 2026

stada ist ein führender hersteller hochwertiger arzneimittel. mit unseren produkten unterstützen wir menschen dabei, gesund und fit zu bleiben und zu werden.

Health > Biotechnology and Pharmaceuticals

Domainstada.com

Year Founded1895

Employees> 10001

Annual Revenue> $1B

STADA

STADA (including company regionals)

stada.com

See more website traffic and engagement information

STADA Revenue up to February 2026 is > 1B

revenue generated by STADA top domains

STADA top domains revenue over 3 years

Revenue for STADA top domains

stada.com> 1B

See more with Sales Intelligence

Total visits to STADA's top domains

Understand STADA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

stada.com68.5K

See more with Sales Intelligence

Avg. visit duration in STADA's top domains

Analyze STADA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

stada.com00:03:01

See more with Sales Intelligence

Avg. pageviews on STADA's top domains

See how STADA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

stada.com2.64

See more with Sales Intelligence

STADA top competitors by domain

Top similar sites in February 2026, ranked by their affinity

hemofarm.comCompany NameHemofarmEmployees1001 - 5000HQMontenegro, PodgoricaAnnual revenue$15M - $25MTotal visits26.1KHeavy Industry and Engineering > Chemical Industry

Top technologies used by STADA

These are the website technologies, by industry, used by STADA top domains

Advertising (6)

DoubleClick

Content Management System (4)

TYPO3

Social (4)

Instagram

Conversion & Analytics (3)

Google Analytics

More Technologies

9

See all

News & Signals from STADA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSTADA Group invests into assets: manufacturing facility in Saudi Arabia, Western Asia, Asia.Stada, a specialty pharma and generic-drug company, has announced an investment of more than EUR 85 million ($101 milion) in a drug-product manufacturing facility in Saudi Arabia.

NewsSTADA Group invested into assets: production facility in the amount of $101M in Saudi Arabia, Western Asia, Asia on Feb 16th '26.Stada will invest more than 85 million euros (around $101 million) to build a new production facility in Saudi Arabia, which will ultimately serve as a supply hub for the broader Middle East and North Africa (MENA) region, the company said in a Feb. 16 press release.

NewsSTADA Group launches Uzpruvo.Alvotech (NASDAQ: ALVO) and its partner STADA Arzneimittel AG have launched Uzpruvo, a biosimilar to Johnson & Johnson's Simponi (golimumab), across several European countries following centralized marketing authorization from the European Commission.